Abstract
Malassezia spp. are lipophilic yeasts not only present in the normal skin microflora, but also responsible of skin-related diseases (pityriasis versicolor, seborrheic/atopic dermatitis and dandruff) as well as systemic fungal infections in humans and animals. Their treatment and eradication are mainly based on old azole drugs, which are characterized by poor compliance, unpredictable clinical efficacy, emerging resistance and several side effects. These drawbacks have prompted the research toward novel synthetic and natural derivatives/ nanomaterials targeting other pivotal enzymes/pathways such as carbonic anhydrase (MgCA) and lipases, alone or in combination, in order to improve the eradication rate of this fungus. This review accomplished an update on this important topic dealing with the latest discoveries of synthetic scaffolds and natural products for the treatment of Malasseziaspp.-related diseases, thus suggesting new opportunities to design innovative and alternative anti-dandruff drugs.
Keywords: Azoles, carbonic anhydrase inhibitors, dandruff, lipase inhibitors, Malassezia spp., natural inhibitors.
Current Medicinal Chemistry
Title:Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents
Volume: 24 Issue: 22
Author(s): Letizia Angiolella, Simone Carradori*, Cristina Maccallini, Gustavo Giusiano and Claudiu T. Supuran
Affiliation:
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti,Italy
Keywords: Azoles, carbonic anhydrase inhibitors, dandruff, lipase inhibitors, Malassezia spp., natural inhibitors.
Abstract: Malassezia spp. are lipophilic yeasts not only present in the normal skin microflora, but also responsible of skin-related diseases (pityriasis versicolor, seborrheic/atopic dermatitis and dandruff) as well as systemic fungal infections in humans and animals. Their treatment and eradication are mainly based on old azole drugs, which are characterized by poor compliance, unpredictable clinical efficacy, emerging resistance and several side effects. These drawbacks have prompted the research toward novel synthetic and natural derivatives/ nanomaterials targeting other pivotal enzymes/pathways such as carbonic anhydrase (MgCA) and lipases, alone or in combination, in order to improve the eradication rate of this fungus. This review accomplished an update on this important topic dealing with the latest discoveries of synthetic scaffolds and natural products for the treatment of Malasseziaspp.-related diseases, thus suggesting new opportunities to design innovative and alternative anti-dandruff drugs.
Export Options
About this article
Cite this article as:
Angiolella Letizia, Carradori Simone *, Maccallini Cristina, Giusiano Gustavo and Supuran T. Claudiu, Targeting Malassezia species for Novel Synthetic and Natural Antidandruff Agents, Current Medicinal Chemistry 2017; 24 (22) . https://dx.doi.org/10.2174/0929867324666170404110631
DOI https://dx.doi.org/10.2174/0929867324666170404110631 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmaceutical Targeting of the Brain
Current Pharmaceutical Design Psychobiome Feeding Mind: Polyphenolics in Depression and Anxiety
Current Topics in Medicinal Chemistry What does the Hospital Anxiety and Depression Scale (HADS) Really Measure in Liaison Psychiatry Settings?
Current Psychiatry Reviews In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Meet Our Editorial Board Member
Current Molecular Pharmacology Significance of CD34 Negative Hematopoietic Stem Cells and CD34 Positive Mesenchymal Stem Cells – A Valuable Dimension to the Current Understanding
Current Stem Cell Research & Therapy Current Management of Traumatic Rupture of the Descending Thoracic Aorta
Current Cardiology Reviews Regulation of Clusterin Gene Expression
Current Protein & Peptide Science Pomegranate as a Possible Treatment in Reducing Risk of Developing Wound Healing, Obesity, Neurodegenerative Disorders, and Diabetes Mellitus
Mini-Reviews in Medicinal Chemistry PREFACE
Current Neuropharmacology Conditional Tat Protein Brain Expression in the GT-tg Bigenic Mouse Induces Cerebral Fractional Anisotropy Abnormalities
Current HIV Research Will Medicinal Cannabinoids Prove to be Useful Clinically?
Current Drug Therapy Salen Mn Complexes are Superoxide Dismutase/Catalase Mimetics that Protect the Mitochondria
Current Inorganic Chemistry (Discontinued) Editorial: Steroid-Dependent Management of Biological Responses in the Nervous System
CNS & Neurological Disorders - Drug Targets A Psychiatric Perspective on Narratives of Self-Reflection in Resilient Adolescents
Adolescent Psychiatry Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Modulation of Midbrain Dopamine Neurotransmission by Serotonin, a Versatile Interaction Between Neurotransmitters and Significance for Antipsychotic Drug Action
Current Neuropharmacology Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer Research NMDA Receptor Antagonists as Antidepressant and Antidementia Drugs: Recent Developments and Future Prospects
Current Medicinal Chemistry - Central Nervous System Agents We are not Alone in Our Body: Insights into the Involvement of Microbiota in the Etiopathogenesis and Pharmacology of Mental Illness
Current Drug Metabolism